Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Todd Neale

February 18, 2019

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Daily News

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

Todd Neale

September 12, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Daily News

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Shelley Wood

July 19, 2016

News Daily News

Debate Directrices EU vs. EE.UU: Según los Expertos las Diferencias son Importantes

Shelley Wood

July 19, 2016

News Industry News

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

July 11, 2016

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Daily News

Higher Consumption of Sugar-Sweetened Beverages Linked With Greater Coronary Artery Calcium

Leah Lawrence

April 26, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Industry News

Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease

March 01, 2016

News Daily News

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

Michael O'Riordan

December 21, 2015

News Industry News

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

October 12, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

Advertisement

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Debate Directrices EU vs. EE.UU: Según los Expertos las Diferencias son Importantes

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Higher Consumption of Sugar-Sweetened Beverages Linked With Greater Coronary Artery Calcium

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Novel Antisense Inhibitor Cuts High Triglyceride Levels

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content